Kalbe Farma Tbk PT
PT Kalbe Farma Tbk is an Indonesian pharmaceutical and healthcare enterprise engaged in manufacturing and distributing healthcare products. The company operates four reportable business divisions: Prescription Pharmaceuticals, Consumer Health, Nutritionals, and Distribution & Logistics. Its core product portfolio encompasses generic prescription drugs, over-the-counter medications, nutritional powders, energy drinks, and third-party medical device distribution. Primary revenue drivers are retail and institutional sales of pharmaceutical and nutritional products across Indonesia and Southeast Asia. Kalbe Farma holds a dominant market position as the largest publicly listed pharmaceutical company in Southeast Asia. The company is headquartered in Jakarta, Indonesia, and its shares trade on the Indonesia Stock Exchange.
10 of the funds FundTelligence covers report a position in Kalbe Farma Tbk PT.
- Sector
- Health Care
- Country
- Indonesia
- Funds holding it
- 10
Funds holding Kalbe Farma Tbk PT
- Nordea Stable Emerging Markets — Nordea Funds · 1.54 % (full portfolio disclosed, July 2026)
- Nordea Asia ex Japan Equity — Nordea Funds · 0.79 % (full portfolio disclosed, September 2026)
- KLP AksjeFremvoksende Markeder Flerfaktor — KLP · 0.4 % (full portfolio disclosed, June 2026)
- Handelsbanken Emerging Markets Index — Handelsbanken · 0.03 % (full portfolio disclosed, September 2026)
- Storebrand Emerging Markets — Storebrand · 0.02 % (full portfolio disclosed, October 2026)
- BlackRock iShares MSCI EM IMI Screened UCITS ETF — BlackRock · 0.01 % (full portfolio disclosed, October 2026)
- Handelsbanken Global Index Criteria — Handelsbanken · 0.01 % (full portfolio disclosed, September 2026)
- Nordea Stabil Balanceret — Nordea Funds · 0.0 % (full portfolio disclosed, July 2026)
Showing the 8 largest of 10 funds holding it.